Practical Guidance for MedTech Reimbursement and Market Access

Clear, practical guidance on what matters most: Coding, Coverage, Payer Strategy, and what it all means for your next milestone.

Medicare Payment Rates Are Just the Beginning: Insight to Private Payer Reimbursement Rates

Learn why Medicare rates are just the floor—and how private payer rates influence hospital decisions and MedTech adoption. ...more

Payer Coverage ,U.S. Healthcare Fundamentals

July 31, 20254 min read

Medicare Payment Rates Are Just the Beginning: Insight to Private Payer Reimbursement Rates

When a Code Is Not Just a Code: What Early-Stage MedTech Founders Need to Know About the Codes “Dr. Google” Identifies

Billing codes can make or break your MedTech strategy. Learn what early-stage founders must know before trusting “Dr. Google” on CPT or HCPCS codes. ...more

Coding and Payment Mechanics ,U.S. Healthcare Fundamentals

July 28, 20254 min read

When a Code Is Not Just a Code: What Early-Stage MedTech Founders Need to Know About the Codes “Dr. Google” Identifies

Medicare Physician Fee Schedule 2026: What Medtech Innovators Should Know

Explore key 2026 Medicare policy changes impacting digital, AI-enabled, and value-based medtech. Understand new signals and plan your next move. ...more

Payer Coverage ,U.S. Healthcare Fundamentals

July 14, 20253 min read

Medicare Physician Fee Schedule 2026: What Medtech Innovators Should Know

WISeR and the Future of Medicare: What Early Targets and Gold Carding Really Tell Us

WISeR introduces prior auth to Medicare — here’s what early targets, tech-enabled reviews, and gold carding signal for MedTech innovators and payers. ...more

Coding and Payment Mechanics ,Payer Coverage &U.S. Healthcare Fundamentals

July 08, 20255 min read

WISeR and the Future of Medicare: What Early Targets and Gold Carding Really Tell Us

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it. ...more

Evidence Planning ,Featured

March 19, 20254 min read

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Featured Insights for MedTech Innovators

Insights to help you validate your pathway, align with payer expectations, and move forward with confidence.

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it. ...more

Evidence Planning ,Featured

March 19, 20254 min read

Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know. ...more

Coding and Payment Mechanics ,Featured

March 04, 20253 min read

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than ... ...more

Payer Coverage ,Featured

February 06, 20254 min read

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after. ...more

Commercialization Planning ,Featured

August 20, 20244 min read

How Hospital Financial Decisions Shape the Fate of New MedTech Innovations

How Hospital Financial Decisions Shape the Fate of New MedTech Innovations

Hospitals are the gatekeepers of device adoption. Learn how to align with their economics. ...more

Commercialization Planning ,Featured

August 07, 20244 min read

Relearning English When it Comes to FDA and CMS Jargon

Relearning English When it Comes to FDA and CMS Jargon

MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement. ...more

U.S. Healthcare Fundamentals ,Featured

June 04, 20241 min read

Helping MedTech innovators achieve widespread reimbursement coverage in the U.S.

© 2025 Coustier Advisory LLC. All rights reserved.

Powered by Rocket Boost